SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?


To: Sidney Merle Foster who wrote (10)10/17/1997 2:29:00 AM
From: technetx  Respond to of 422
 
Sid,

Earnings probably did have something to do with stock rise. Earnings beat First CAll's expectations by .02 ( .05 expected by First Call as predicted on 6/2/97). also 17% rise in revenue is nice.

After the ABS is approved, BLUD will be that company you have been waiting for.....the company we all have been waiting for.

Dominic



To: Sidney Merle Foster who wrote (10)10/2/1999 1:45:00 PM
From: Thomas Kirwin  Read Replies (1) | Respond to of 422
 
One Day Jump - 13.54%

Immucor jumped 13.54% or $1 5/8 on no news Friday October 1st. Over 115,000
shares traded hands, more than 100% the daily average. Hmmmmmmm!

I see a technical rally as Immucor was way oversold.

Best O'Luck!

Tom